Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aminocaproic acid

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with aminocaproic acid in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(aminocaproic acid)
Trials
(aminocaproic acid)
Recent Studies (post-2010) (aminocaproic acid)
9,1561875521,793132302

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bulbena, O; Casanovas, LI; Escolar, G; Galmés, JL; Navarro, C1
Crooks, S; Knox, P; Patel, S; Scaife, MC1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aminocaproic acid

ArticleYear
Zinc acexamate reduces gastric damage induced by platelet-activating factor.
    Prostaglandins, leukotrienes, and essential fatty acids, 1989, Volume: 38, Issue:1

    Topics: Aminocaproates; Aminocaproic Acid; Animals; Blood Pressure; Gastric Mucosa; Male; Mast Cells; Platelet Activating Factor; Rats; Rats, Inbred Strains; Stomach; Stomach Ulcer

1989
Role of plasminogen, plasmin, and plasminogen activators in the migration of fibroblasts into plasma clots.
    Journal of cellular physiology, 1987, Volume: 132, Issue:3

    Topics: Aminocaproic Acid; Blood Coagulation; Cell Count; Cell Movement; Dose-Response Relationship, Drug; Fibrinolysin; Fibrinolysis; Fibroblasts; Humans; Plasminogen; Platelet Activating Factor

1987